-
Bank of America Raises PT On Johnson & Johnson To $67
Wednesday, April 20, 2011 - 5:51am | 28Bank of America has raised the price objective on Johnson & Johnson (NYSE: JNJ) from $65 to $67 and maintains its Neutral rating.
-
Elan Reports Q1 EPS of $0.12
Wednesday, April 20, 2011 - 5:35am | 52Elan Corp (NYSE: ELN) reported its Q1 diluted EPS at $0.12. ELN reported its Q1 revenue at $313.0 million, versus the consensus of $297.04 million. ELN shares gained 1.22% to $8.27 in pre-market trading. Read more from Benzinga's Company news.
-
Earnings Scheduled For April 20 (ABT, NDAQ, MO, UNP, AAPL, MAR, T, QCOM, AXP, WFC, AMGN, FCX, AMR, YUM, ETFC, UTX)
Wednesday, April 20, 2011 - 12:24am | 426Abbott Laboratories (NYSE: ABT) is expected to report its Q1 EPS at $0.90 on revenue of $8.81 billion. Nasdaq OMX Group Inc (NASDAQ: NDAQ) is estimated to post its Q1 earnings at $0.61 per share on revenue of $408.73 million. Altria Group Inc (NYSE: MO) is estimated to post its Q1 earnings at $0....
-
Earnings Scheduled For April 20 (ABT, NDAQ, MO, UNP, AAPL, MAR, T, QCOM, AXP, WFC, AMGN, FCX, AMR, YUM, ETFC, UTX)
Wednesday, April 20, 2011 - 12:19am | 426Abbott Laboratories (NYSE: ABT) is expected to report its Q1 EPS at $0.90 on revenue of $8.81 billion. Nasdaq OMX Group Inc (NASDAQ: NDAQ) is estimated to post its Q1 earnings at $0.61 per share on revenue of $408.73 million. Altria Group Inc (NYSE: MO) is estimated to post its Q1 earnings at $0....
-
Jumping Mid-term Support 04-19-2011
Tuesday, April 19, 2011 - 7:24pm | 876Cusick's Corner The market action confirmed that the major trend in Equities is intact, plus earnings After Hours are supporting the move as well. The market finished not only in the green, but most importantly key bench marks like the S&P June Futures jumped above mid-term support, 50-Day...
-
Trading Turns Mixed 04-19-2011
Tuesday, April 19, 2011 - 3:28pm | 968Cusick's Corner The newest S&P rating is vetting itself throughout the financial shows, keeping viewers, but the reality is that the US going into default is not a reality. It has put more pressure on politicians but the market knows that the credit markets are not going to shut down. Plus...
-
Jefferies Comments On Johnson & Johnson's Q1:11 Results
Tuesday, April 19, 2011 - 1:58pm | 153According to Jefferies, Johnson & Johnson's (NYSE: JNJ) Q1:11 results and comments point toward improving pricing, volume, and utilization trends in select divisions. Jefferies reported that read-through is neutral-to-positive for competing companies in our universe including COV, BCR on the...
-
Trouble in Paradise? Five Stocks Near 52-Week Highs with Abnormally High Debt-to-Capital Ratios (CAR, CHTR, NLY, ELN, LBTYA)
Tuesday, April 19, 2011 - 11:39am | 523A company's debt-to-capital ratio is a measurement of its total debt relative to its total capital. The debt incorporates all short- and long-term obligations, whereas total capital incorporates the company's shareholder equity (common stock, preferred stock, minority interests, etc.) and net debt...
-
Top Percentage Gainers and Losers as of 10am 4/19/11 (SIFY, FSII, REDF, HNSN, DANG, LLEN, CLWR, AMRN, GNK, OWW)
Tuesday, April 19, 2011 - 10:08am | 214Best 1) Sify Technologies (NASDAQ: SIFY): Trading up 12% from yesterday's close to $6.55. A positive article from The Motley Fool yesterday afternoon has shares higher today. 2) FSI International (NASDAQ: FSII): Trading up 9.6% from yesterday's close to $4.23. 3) Rediff.com India (NASDAQ: REDF...
-
Hapoalim Upgrades LLY From Hold To Buy, Raises PT To $39
Tuesday, April 19, 2011 - 9:34am | 95Hapoalim is upgrading shares of Eli Lilly & Co. (NYSE: LLY) from Hold to Buy. “We are also increasing our Price Target to $39,” Hapoalim writes. “As a result of better-than-expected 1Q sales, we are increasing our 2011-2014 revenue estimates. Additionally as a result of higher than expected...
-
News Summary
Tuesday, April 19, 2011 - 9:32am | 227Shares of Harley-Davidson Inc (NYSE: HOG) fell about 3% after the company reported its Q1 earnings at $119.3 million, or $0.51 per share, up from $33.3 million, or $0.14 per share, in the year-earlier period. The company's revenue increased to $1.06 billion from $1.04 billion. However, analysts...
-
Johnson & Johnson Conference Call Notes (JNJ)
Tuesday, April 19, 2011 - 9:19am | 39Johnson & Johnson (NYSE: JNJ) says "still more work to do on Japan operations... seeing sequential improvements from yr-ago... `making good progress' in Mcneil... 2011 sales $65.5b including currency impact... dividend remains priority."
-
Pre-market News and Views
Tuesday, April 19, 2011 - 9:18am | 446S&P 500 e-mini futures(ES M1) have erased an overnight decline and are trading positive by 2.50 points to 1303.50 per contract this morning. A positive reaction to corporate earnings in some leading stocks such as Johnson and Johnson(NYSE: JNJ), and Goldman Sachs Group Inc.(NYSE: GS) are...
-
Life Tech Capital Reports On NovaBay's NeutroPhase
Tuesday, April 19, 2011 - 9:12am | 171According to Life Tech Capital, NovaBay Pharmaceuticals (NYSE: NBY) presented a poster on the efficacy of NeutroPhase (NVC-101) solution with Pioneer Technology's (private) hydrophobic mesh Sorbact in healing chronic non-healing wounds at the 2011 Symposium on Advanced Wound Care (SAWC) in Dallas...
-
Forest Laboratories and Blue Ash Therapeutics Enter Into Asset Purchase Agreement for Azimilide, a Novel Phase III Antiarrhythmic Agent (FRX)
Tuesday, April 19, 2011 - 8:33am | 134Forest Laboratories, Inc. (NYSE: FRX) today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent...